Phio recently presented new data from the ongoing clinical trial showing that, of the two patients who have completed treatment in the second dose cohort, one patient with cutaneous squamous cell ...

Brain tumors could soon be detected by robots, according to a new study. Artificial intelligence (AI) models can be trained ...

A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win.

Valley fever cases are up almost 50% in Arizona in 2024. It's not contagious as a person has to be exposed to fungal spores ...

The National Institutes of Health has awarded the Oklahoma Medical Research Foundation a $412,610 grant for research aimed at ...

November 14, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company exploring new pathways towards a cancer-free future by using its INTASYL ® siRNA gene silencing ...

The partnership will focus on supporting the clinical development of Parabilis’ lead program, FOG-001, in colorectal cancer.

AdventHealth claims top spot; Cleveland Clinic elevated to Masters Category joining Mayo Clinic and Intermountain Healthcare.

A tool powered by artificial intelligence that uses high-speed video to detect changes in blood flow in skin on the face and hands may offer a new way to screen ...

Ariel Investments, an investment management company, released its “Ariel Focus Fund” third-quarter 2024 investor letter. A ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” third quarter 2024 investor letter.